Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 16;9(6):e023994.
doi: 10.1136/bmjopen-2018-023994.

Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments

Camille Chenevier-Gobeaux  1 , Mustapha Sebbane  2 , Christophe Meune  3   4 , Sophie Lefebvre  2 , Anne-Marie Dupuy  5 , Guillaume Lefèvre  6   7 , Nicolas Peschanski  8 , Patrick Ray  9   10
Affiliations

Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments

Camille Chenevier-Gobeaux et al. BMJ Open. .

Abstract

Objectives: Copeptin and high-sensitivity cardiac troponin (HS-cTn) assays improve the early detection of non-ST-segment elevation myocardial infarction (NSTEMI). Their sensitivities may, however, be reduced in very early presenters.

Setting: We performed a post hoc analysis of three prospective studies that included patients who presented to the emergency department for chest pain onset (CPO) of less than 6 hours.

Participants: 449 patients were included, in whom 12% had NSTEMI. CPO occurred <2 hours from ED presentation in 160, between 2 and 4 hours in 143 and >4 hours in 146 patients. The prevalence of NSTEMI was similar in all groups (9%, 13% and 12%, respectively, p=0.281).

Measures: Diagnostic performances of HS-cTn and copeptin at presentation were examined according to CPO. The discharge diagnosis was adjudicated by two experts, including cardiac troponin I (cTnI). HS-cTn and copeptin were blindly measured.

Results: Diagnostic accuracies of cTnI, cTnI +copeptin and HS-cardiac troponin T (HS-cTnT) (but not HS-cTnT +copeptin) lower through CPO categories. For patients with CPO <2 hours, the choice of a threshold value of 14 ng/L for HS-cTnT resulted in three false negative (Sensitivity 80%(95% CI 51% to 95%); specificity 85% (95% CI 78% to 90%); 79% of correctly ruled out patients) and that of 5 ng/L in two false negative (sensitivity 87% (95% CI 59% to 98%); specificity 58% (95% CI 50% to 66%); 52% of correctly ruled out patients). The addition of copeptin to HS-cTnT induced a decrease of misclassified patients to 1 in patients with CPO <2 hours (sensitivity 93% (95% CI 66% to 100%); specificity 41% (95% CI 33% to 50%)).

Conclusion: A single measurement of HS-cTn, alone or in combination with copeptin at admission, seems not safe enough for ruling out NSTEMI in very early presenters (with CPO <2 hours).

Trial registration number: DC-2009-1052.

Keywords: chest pain; chest pain onset; copeptin; high sensitive cardiac troponin; non st-elevation acute myocardial infarction; very early presenters.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CC-G, PR and CM received honorarias and lecture fees from Roche Diagnostics andThermofisher Scientific.

Figures

Figure 1
Figure 1
Flow chart of the studied population. CPO, chest pain onset; cTnI, cardiac troponin I; STEMI, ST-segment elevation myocardial infarction.
Figure 2
Figure 2
ROC curves of cTn for the diagnosis of NSTEMI, alone or in combination with copeptin. (A) CPO <2 hours; (B) CPO 2–4 hours; (C) CPO >4 hours. AUC, area under the ROC curve; cTn, cardiac troponin; cTnI, cardiac troponin I; CPO, chest pain onset; HS-cTnT, high-sensitivity cardiac troponin T; ROC, receiver operating characteristic; NSTEMI, non-ST-segment elevation myocardial infarction.
See this image and copyright information in PMC

References

    1. Roffi M, Patrono C, Collet JP, et al. . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 20162016;37:267–315. - PubMed
    1. Mueller C, Giannitsis E, Christ M, et al. . Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. Ann Emerg Med 2016;68:76–87. 10.1016/j.annemergmed.2015.11.013 - DOI - PubMed
    1. Wildi K, Nelles B, Twerenbold R, et al. . Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J 2016;181:16–25. 10.1016/j.ahj.2016.07.013 - DOI - PubMed
    1. Boeddinghaus J, Nestelberger T, Twerenbold R, et al. . Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I. Circulation 2017;135:1597–611. 10.1161/CIRCULATIONAHA.116.025661 - DOI - PubMed
    1. Pickering JW, Than MP, Cullen L, et al. . Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. Ann Intern Med 2017;166:715–24. 10.7326/M16-2562 - DOI - PubMed